Transfusion-dependent Beta-Thalassemia
20 clinical trials · Condition
◉ Watch Transfusion-dependent Beta-Thalassemia
| Record | Firm | Date |
|---|---|---|
| EDIT-301 for Autologous Hematopoietic Stem Cell Transplant (HSCT) in Participants With Transfusion-Dependent Beta Thalassemia (TDT) (NCT05444894) | Editas Medicine, Inc. | 2022-04-29 |
| Deciphering Effects of Thalidomide on Red Blood Cells in Transfusion Dependents Beta Thalassemia Patients (NCT06146478) | Blood Care Clinic | 2022-01-25 |
| A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) (NCT04770779) | Agios Pharmaceuticals, Inc. | 2021-11-30 |
| A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT) (NCT03432364) | Sangamo Therapeutics | 2018-03-29 |
| Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated With Ex Vivo Gene Therapy (NCT02633943) | Genetix Biotherapeutics Inc. | 2014-01-01 |
Track Transfusion-dependent Beta-Thalassemia automatically
Every clearance here is in the API, with alerts when new ones post.